Media Summary: Steve Singer, Vice President of Education and Outreach, Accreditation Council for Continuing Medical Education; Richard Bottner, ... Andrey Ostrovsky, Managing Partner, Social Innovation Ventures; Corey Waller, Principal, Health Management Associates; Kelly ... ... Medical Officer, HCA Healthcare, provide opening remarks at the

Nam Opioid Collaborative 5 21 Virtual Symposium Session 2 - Detailed Analysis & Overview

Steve Singer, Vice President of Education and Outreach, Accreditation Council for Continuing Medical Education; Richard Bottner, ... Andrey Ostrovsky, Managing Partner, Social Innovation Ventures; Corey Waller, Principal, Health Management Associates; Kelly ... ... Medical Officer, HCA Healthcare, provide opening remarks at the Helen Burstin, CEO, Council of Medical Specialty Societies; Roger Chou, Professor in the Departments of Medicine, and Medical ... Alonzo Plough, Chief Science Officer, Robert Wood Johnson Foundation; Elizabeth Salisbury-Afshar, Director, Center for ... Kelly Clark, Immediate Past President, American Society of Addiction Medicine; Matthew Stefanko, Director, National Stigma ...

... of Stigma: Perspectives from Persons with Lived Experience at the Victor Dzau, Ruth Katz, and Jonathan Perlin provide opening remarks and an overview of the work of the Kelly Clark and Carlos Blanco provide an overview of the work of the Research, Data, and Metrics working group of the Kathy Chappell and Steve Singer present an overview of the Health Professional Education and Training working group of the ... Alonzo Plough, Jay Bhatt, and Andrey Ostrovsky present an overview of the work of the Prevention, Treatment, and Recovery ... Kassandra Frederique, Executive Director of the Drug Policy Alliance, provides a keynote address focused on the intersection of ...

Helen Burstin and Debra Houry provide an overview of the work of the Pain Management Guidelines and Evidence Standards ... Consortium on Substance Use and Addiction 6th Annual This is the second panel of the Journal of Law in Society's 2021 Hi everyone welcome to the second annual university of michigan injury prevention center research ... naloxone distribution among laypersons and emergency personnel could prevent up to Terry Horton,M.D. and Claudine Jurkovitz, M.D., MPH share their findings in a presentation entitled: Validation of the

Photo Gallery

NAM Opioid Collaborative 5.21 Virtual Symposium - Session 2
NAM Opioid Collaborative 5.21 Virtual Symposium - Session 5
NAM Opioid Collaborative 5.21 Virtual Symposium - Welcome and Opening Remarks
NAM Opioid Collaborative 5.21 Virtual Symposium - Session 3
NAM Opioid Collaborative 5.21 Virtual Symposium - Session 4
NAM Opioid Collaborative 5.21 Virtual Symposium - Session 1
NAM Opioid Collaborative 5.21 Virtual Symposium - Keynote Presentations
Introduction and Welcome - Opioid Collaborative Virtual Symposium Nov 2020
Research, Data, and Metrics - Opioid Collaborative Virtual Symposium Nov 2020
Health Professional Education and Training - Opioid Collaborative Virtual Symposium Nov 2020
Prevention, Treatment, and Recovery - Opioid Collaborative Virtual Symposium November 2020
Keynote Presentation - Opioid Collaborative Virtual Symposium Nov 2020
Sponsored
Sponsored
View Detailed Profile
NAM Opioid Collaborative 5.21 Virtual Symposium - Session 2

NAM Opioid Collaborative 5.21 Virtual Symposium - Session 2

Steve Singer, Vice President of Education and Outreach, Accreditation Council for Continuing Medical Education; Richard Bottner, ...

NAM Opioid Collaborative 5.21 Virtual Symposium - Session 5

NAM Opioid Collaborative 5.21 Virtual Symposium - Session 5

Andrey Ostrovsky, Managing Partner, Social Innovation Ventures; Corey Waller, Principal, Health Management Associates; Kelly ...

Sponsored
NAM Opioid Collaborative 5.21 Virtual Symposium - Welcome and Opening Remarks

NAM Opioid Collaborative 5.21 Virtual Symposium - Welcome and Opening Remarks

... Medical Officer, HCA Healthcare, provide opening remarks at the

NAM Opioid Collaborative 5.21 Virtual Symposium - Session 3

NAM Opioid Collaborative 5.21 Virtual Symposium - Session 3

Helen Burstin, CEO, Council of Medical Specialty Societies; Roger Chou, Professor in the Departments of Medicine, and Medical ...

NAM Opioid Collaborative 5.21 Virtual Symposium - Session 4

NAM Opioid Collaborative 5.21 Virtual Symposium - Session 4

Alonzo Plough, Chief Science Officer, Robert Wood Johnson Foundation; Elizabeth Salisbury-Afshar, Director, Center for ...

Sponsored
NAM Opioid Collaborative 5.21 Virtual Symposium - Session 1

NAM Opioid Collaborative 5.21 Virtual Symposium - Session 1

Kelly Clark, Immediate Past President, American Society of Addiction Medicine; Matthew Stefanko, Director, National Stigma ...

NAM Opioid Collaborative 5.21 Virtual Symposium - Keynote Presentations

NAM Opioid Collaborative 5.21 Virtual Symposium - Keynote Presentations

... of Stigma: Perspectives from Persons with Lived Experience at the

Introduction and Welcome - Opioid Collaborative Virtual Symposium Nov 2020

Introduction and Welcome - Opioid Collaborative Virtual Symposium Nov 2020

Victor Dzau, Ruth Katz, and Jonathan Perlin provide opening remarks and an overview of the work of the

Research, Data, and Metrics - Opioid Collaborative Virtual Symposium Nov 2020

Research, Data, and Metrics - Opioid Collaborative Virtual Symposium Nov 2020

Kelly Clark and Carlos Blanco provide an overview of the work of the Research, Data, and Metrics working group of the

Health Professional Education and Training - Opioid Collaborative Virtual Symposium Nov 2020

Health Professional Education and Training - Opioid Collaborative Virtual Symposium Nov 2020

Kathy Chappell and Steve Singer present an overview of the Health Professional Education and Training working group of the ...

Prevention, Treatment, and Recovery - Opioid Collaborative Virtual Symposium November 2020

Prevention, Treatment, and Recovery - Opioid Collaborative Virtual Symposium November 2020

Alonzo Plough, Jay Bhatt, and Andrey Ostrovsky present an overview of the work of the Prevention, Treatment, and Recovery ...

Keynote Presentation - Opioid Collaborative Virtual Symposium Nov 2020

Keynote Presentation - Opioid Collaborative Virtual Symposium Nov 2020

Kassandra Frederique, Executive Director of the Drug Policy Alliance, provides a keynote address focused on the intersection of ...

Pain Management Guidelines and Evidence Standards - Opioid Collaborative Symposium Nov 2020

Pain Management Guidelines and Evidence Standards - Opioid Collaborative Symposium Nov 2020

Helen Burstin and Debra Houry provide an overview of the work of the Pain Management Guidelines and Evidence Standards ...

2025 Consortium on Substance Use and Addiction Conference

2025 Consortium on Substance Use and Addiction Conference

Consortium on Substance Use and Addiction 6th Annual

JLS 2021 Symposium: "Opioid Paradigms" - Panel 2 Opioids and Emerging Justice Reforms

JLS 2021 Symposium: "Opioid Paradigms" - Panel 2 Opioids and Emerging Justice Reforms

This is the second panel of the Journal of Law in Society's 2021

Abstract Session Opioid and Overdose U-M IPC 2021 Virtual Research Symposium

Abstract Session Opioid and Overdose U-M IPC 2021 Virtual Research Symposium

Hi everyone welcome to the second annual university of michigan injury prevention center research

Meeting the Moment: Opioid Series - Session 2

Meeting the Moment: Opioid Series - Session 2

How the

Webinar TWO: Best Practices for Opioid Education and Naloxone Distribution

Webinar TWO: Best Practices for Opioid Education and Naloxone Distribution

... naloxone distribution among laypersons and emergency personnel could prevent up to

2018 Value Institute Spring Symposium: Opioid Screening Presentation

2018 Value Institute Spring Symposium: Opioid Screening Presentation

Terry Horton,M.D. and Claudine Jurkovitz, M.D., MPH share their findings in a presentation entitled: Validation of the

Public Meeting: Patient-Focused Drug Development for Opioid Use Disorder - Part 2

Public Meeting: Patient-Focused Drug Development for Opioid Use Disorder - Part 2

On April 17, 2018, FDA hosted a public